Delivery Order SPE2DB25D3003-SPE2DB25FPVQT
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,245.58, is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Firm Fixed Price type and has an ultimate completion date of December 18, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,732.07, is for the supply of 4562705177 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.56, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. This is a firm fixed-price delivery order contract with a completion date of January 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,206.40 firm-fixed-price contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a specialty pharmaceutical product. The order has a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $11,946.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a specialty medication used for diabetes management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 23, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $28,673.28 and a completion date of January 31, 2024. This delivery order is issued under a single award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025. The IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.21, is for the delivery of insulin aspart 100 unit/mL pen 3mL. The contract has a completion date of June 27, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, with a ceiling value of $26,133.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML medical supplies, with a performance period ending on January 17, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating...
This federal contract award, valued at $15,787.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of insulin aspart 100 unit/mL pen 3mL, a prescription medication used in the management of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 2, 2024. It is not designated as a set-aside...